Orchid Pharma Revenue

In the fiscal year ending March 31, 2025, Orchid Pharma had annual revenue of 9.22B INR with 12.52% growth. Orchid Pharma had revenue of 2.37B in the quarter ending March 31, 2025, with 9.39% growth.

Revenue

9.22B

Revenue Growth

+12.52%

P/S Ratio

4.16

Revenue / Employee

10.58M

Employees

871

Market Cap

38.35B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	9.22B	1.03B	12.52%
Mar 31, 2024	8.19B	1.53B	23.05%
Mar 31, 2023	6.66B	1.06B	19.00%
Mar 31, 2022	5.60B	1.09B	24.33%
Mar 31, 2021	4.50B	-337.41M	-6.97%
Mar 31, 2020	Pro	Pro	Pro
Mar 31, 2019	Pro	Pro	Pro
Mar 31, 2018	Pro	Pro	Pro
Mar 31, 2017	Pro	Pro	Pro
Mar 31, 2016	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Sun Pharmaceutical Industries	525.78B
Divi's Laboratories	93.60B
Cipla	272.67B
Apollo Hospitals Enterprise	217.94B
Zydus Lifesciences	232.42B
Mankind Pharma	122.07B
Aurobindo Pharma	317.24B
Fortis Healthcare	77.83B

Revenue Rankings

Orchid Pharma News

5 weeks ago - Orchid Pharma shares drop nearly 5% as Q4 net profit falls 32.4% YoY to Rs 22.3 crore - Business Upturn
4 months ago - Orchid Pharma shares surge 4.4% after successful USFDA inspection at Alathur API facility - Business Upturn
4 months ago - Orchid Pharma successfully completes USFDA inspection at Alathur API facility, secures EU GMP certification renewal - Business Upturn
5 months ago - Orchid Pharma shares drop over 14% as net profit falls 25.63% YoY to ₹22.45 crore in Q3 - Business Upturn
8 months ago - Orchid Pharma shares jump nearly 4% following strong Q2 FY25 results - Business Upturn
8 months ago - Orchid Pharma Q2 FY25 Results: Revenue jumps 12% to ₹222.7 crore, PAT up 26% YoY - Business Upturn

More News